Evidence map›Paper›PMID 40109922›Full record

ReviewRSC advances2025

Recent advances of silver nanoparticle-based polymer nanocomposites for biomedical applications.

Mohammad Harun-Ur-Rashid, Tahmina Foyez, Suresh Babu Naidu Krishna, Sudhakar Poda, Abu Bin Imran

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. RSC advances · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad Harun-Ur-RashidDepartment of Chemistry, International University of Business Agriculture and Technology (IUBAT) Sector 10, Uttara Model Town Dhaka 1230 Bangladesh mrashid@iubat.edu.ORCID https://orcid.org/0000-0003-1883-4620
Tahmina FoyezDepartment of Pharmacy, School of Life Sciences, United International University United City, Madani Ave Dhaka 1212 Bangladesh tahmina@pharmacy.uiu.ac.bd.ORCID https://orcid.org/0000-0002-8875-3888
Suresh Babu Naidu KrishnaInstitute for Water and Wastewater Technology, Durban University of Technology P. O. Box 1334 Durban 4000 South Africa sureshk@dut.ac.za.ORCID https://orcid.org/0000-0003-3155-8878
Sudhakar PodaDepartment of Biotechnology, Acharya Nagarjuna University Andhra Pradesh India sudhakarp@anu.ac.in.ORCID https://orcid.org/0000-0003-1467-9328
Abu Bin ImranDepartment of Chemistry, Bangladesh University of Engineering and Technology (BUET) Dhaka 1000 Bangladesh abimran@chem.buet.ac.bd.ORCID https://orcid.org/0000-0001-8920-8921

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticle-polymer nanocomposites (AgNP-PNCs) represent a transformative advancement in biomedical material science, integrating the potent antimicrobial properties of AgNPs with the structural versatility of polymer matrices. This synergy enables enhanced infection control, mechanical stability, and controlled drug delivery, making these nanocomposites highly suitable for applications such as wound healing, medical coatings, tissue engineering, and biosensors. Recent progress in synthesis and functionalization has led to greater control over particle morphology, dispersion, and stability, optimizing AgNP-PNCs for clinical and translational applications. However, challenges related to cytotoxicity, long-term stability, immune response, and scalability persist, necessitating systematic improvements in surface functionalization, hybridization strategies, and biocompatibility assessments. This review critically evaluates the latest advancements in AgNP-PNC development, focusing on their functionalization techniques, regulatory considerations, and emerging strategies to overcome biomedical challenges. Additionally, it discusses preclinical and translational aspects, including commercialization barriers and regulatory frameworks such as FDA and EMA guidelines, ensuring a comprehensive outlook on their clinical feasibility. By bridging the gap between innovation and practical application, this review investigates the transformative potential of AgNP-PNCs in advancing next-generation biomedical materials.

Identifiers

PMID40109922
PMCPMC11920860

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.